Market capitalization | $470.44m |
Enterprise Value | $470.71m |
P/E (TTM) P/E ratio | 19.94 |
EV/FCF (TTM) EV/FCF | 7.13 |
EV/Sales (TTM) EV/Sales | 62.18 |
P/S ratio (TTM) P/S ratio | 62.15 |
P/B ratio (TTM) P/B ratio | 0.87 |
Dividend yield | 7.90% |
Last dividend (FY25) | $2.90 |
As a Free StocksGuide user, you can view scores for all 6,845 stocks worldwide.
Dec '24 |
+/-
%
|
||
Revenue | 7.57 7.57 |
8%
8%
|
|
Gross Profit | 7.57 7.57 |
92%
92%
|
|
EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | 0.93 0.93 |
54%
54%
|
Net Profit | 24 24 |
20%
20%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
BlackRock Health Sciences Trust is a closed-end investment fund. Its investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The company was founded on March 31, 2005 and is headquartered in Wilmington, DE.
Head office | United States |
CEO | John Perlowski |
Founded | 2005 |
Website | www.blackrock.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.